$4.54
-0.06 (-1.30%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+602.2% upside
Low Target
$19.01
Average Target
$31.88
High Target
$45.37
Current Price
$4.54
Current
$4.54
$4.54
Target
$31.88
$31.88
$19.01
$31.88 avg
$45.37
Scenario Analysis
Bear Case
$19.01
318.7%
Low target
Base Case
$31.88
+602.2%
Avg target
Bull Case
$45.37
+899.3%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$28.90
-84.3% from high
52-Week Low
$16.28
+-72.1% from low
Target vs 52W High
$31.88
+10.3% vs high
Next Earnings Report
Feb 26, 2026 · After Market Close
10d
until earnings
EPS Est: $-0.52
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |